Cabazitaxel Ideogen 60 mg/1.5 ml Konzentrat und Lösungsmittel zur Herstellung einer Infusionslösung
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
cabazitaxelum
Available from:
IDEOGEN AG
ATC code:
L01CD04
INN (International Name):
cabazitaxelum
Pharmaceutical form:
Konzentrat und Lösungsmittel zur Herstellung einer Infusionslösung
Composition:
Solutio concentrata: cabazitaxelum 60 mg, polysorbatum 80, q.s. ad solutionem pro 1.5 ml. Solvens: ethanolum 96 per centum 0.585 ml, aqua ad iniectabile q.s. ad solutionem pro 4.5 ml corresp. ethanolum 13 % V/V.
Class:
A
Therapeutic group:
Synthetika
Therapeutic area:
Zytostatikum
Authorization status:
zugelassen
Authorization date:
2021-07-20
